Assessment of toxic potential of industrial chemicals using a cultured human bioartificial skin model: Production of interleukin 1α and hydroxyeicosatetraenoic acids

Skin Pharmacology and Applied Skin Physiology

Volumn 13, Issue 5, 2000, Pages 246-257

  Yang, Eun Kyung ^a   Yoon, Hee Hoon ^a   Lee, Doo Hoon ^a   Park, Jung Keug ^a  

^a Dongguk University   (South Korea)

Author keywords

Artificial skin; Cutaneous toxicity; Hydroxyeicosatetraenoic acid (HETE); Interleukin 1 (IL 1 ); Proinflammatory mediator

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; INDUSTRIAL CHEMICAL; INTERLEUKIN 1ALPHA;

ARTICLE; ARTIFICIAL SKIN; CYTOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; MEDIATOR RELEASE; MITOGENICITY; MONOLAYER CULTURE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN CULTURE; SKIN IRRITATION; SKIN TOXICITY; SOLUBILIZATION;

EID: 0342955713     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029930     Document Type: Article

References (26)

1. Gay R, Swiderek M, Nelson D, Ernesti A: The living skin equivalent as a model in vitro or ranking the toxic potential of dermal irritants. Toxicol In Vitro 1992;6:303-315.
2. Dykes PJ, Edwards MJ, O'Donovan MR, Merrett V, Morgan HE, Marks R: In vitro reconstruction of human skin: The use of skin equivalents as potential indicators of cutaneous toxicity. Toxicol In Vitro 1991;5: 1-8.
3. Bell E, Ehrlich P, Buttle DJ, Nakatsuji T: Living tissue formed in vitro and accepted as skin-equivalent of full thickness. Science 1981;221: 1052-1054.
4. Yang EK, Jin SW, Kang BT, Kim IH, Park JK, Lee SS, Kim JW, Park SN: Construction of artificial epithelial tissues prepared from human normal fibroblasts and C9 cervical epithelial cancer cells carrying human papillomavirus type 18 genes. Biotechnol Bioprocess Eng 1998;3: 1-5.
5. Saiag P, Bell E: Psoriatic fibroblasts induce hyperproliferation of normal keratinocytes in a skin equivalent model in vitro. Science 1985;230: 669-672.
6. Hull BE, Sher SE, Rosen S, Church D, Bell E: Structural integration of skin equivalents grafted to Lewis and Sprague-Dawley rats. J Invest Dermatol 1983;81:429-436.
7. Augustin C, Frei V, Perrier E, Huc A, Damour O: A skin equivalent model for cosmetological trials: An in vitro efficacy study of a new biopeptide. Skin Pharmacol 1997;10: 63-70.
8. De Nucci G: Eicosanoids and skin. Biochem Soc Trans 1988;16:680-682.
9. Kondo T, Ohshima T: The dynamics of inflammatory cytokines in the healing process of mouse skin wound: A preliminary study for possible wound age determination. Int J Legal Med 1996;108:231-236.
10. Coulomb B, Friteau L, Dubertrel L: Biafine applied on human epidermal wounds is chemotactic for macrophages and increases the IL-1/IL-6 ratio. Skin Pharmacol 1997;10:281-287.
11. Vogt PM, Lehnhard M, Wagner D, Jansen V, Krieg M, Steinau HU: Determination of endogenous growth factors in human wound fluid: Temporal presence and profiles of secretion. Plast Reconstr Surg 1998;102: 117-123.
12. Kragballe K, Fallon JD: Increased aggregation and arachidonic acid transformation by psoriatic platelets: Evidence that platelet-derived 12-hydroxy-eicosatetraenoic acid increases keratinocyte DNA synthesis in vitro. Arch Dermatol Res 1986;278:449-453.
13. DeLco V, Harber L, Kong B, DeSalva S: Surfactant induced alteration of arachidonic acid metabolism of mammalian cells in culture. Proceedings of the Society for Experimental Biology and Medicine 1987; 184:477-482.
14. Yang EK, Seo YK, Youn HH, Lee DH, Park SN, Park JK: Tissue engineered artificial skin composed of dermis and epidermis. Artif Organs 2000;24:7-17.
15. Yang EK, Lee DH, Park SN, Choe TB, Park JK: Contraction behavior of collagen gel and fibroblasts activity in dermal equivalent model. J Microbiol Biotechnol 1997;7:267-271.
16. Eskra JD, Pereira MJ, Ernest MJ: Solid-phase extraction and high-performance liquid chromatography analysis of lipoxygenase pathway products. Anal Biochem 1986;154: 332-337.
17. Bell E, Parenteau N, Gay R, Nolte C, Kemp P, Bilbo P, Ekstein B, Johnson E: The living skin equivalent: Its manufacture, its organotypic properties and its responses to irritants. Toxicol In Vitro 1991;5: 591-596.
18. Yang EK, Seo YK, Lee DH, Lee JH, Kim J, Yook JI, Park JH, Park JK: Fabrication of collagen sponge incorporated with collagen threads. Biomater Res 1999;3:60-65.
19. van de Sandt JJM, Bos TA, Rutten AAJJL: Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulfate. In Vitro Cell Dev Biol Animal 1995;31:761-766.
20. Elias PM: Structure and function of the stratum corneum permeability barrier. Drug Dev Res 1988;13:97-105.
21. Ponec M, Kempenaar J: Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants. Skin Pharmacol 1995;8:49-59.
22. Burrall AB, Wintroub BU, Goetzl EJ: Selective expression of 15-lipoxygenase activity by cultured human keratinocytes. Biochem Biophys Res Commun 1985;133:208-213.
23. Mayer B, Rauter L, Zenzmaier E, Gleispach H, Esterbauer H: Characterization of lipoxygenase metabolites of arachidonic acid in cultured human skin fibroblasts. Biochim Biophys Acta 1984;795:151-161.
24. Corsini E, Bruccolen A, Marinovich M, Galli CL: Endogenous interleukin-1α is associated with skin irritation induced by tributyltin. Toxicol Appl Pharmacol 1996;138:268-274.
25. Rikimaru T, Nakamura M, Yano T, Beck G, Habicht GS, Rennie L, Widra M, Hirshman CA, Boulay MG, Spannhake EW, Lazarus GS, Pula PJ, Dannenberg AM Jr: Mediators, initiating the inflammatory response, released in organ culture by full-thickness human skin explants exposed to the irritant, sulfur mustard. J Invest Dermatol 1991;96: 888-897.
26. Barr RM, Brain S, Camp RDR, Cilliers J, Greaves MW, Mallet AI, Misch K: Levels of arachidonic acid and its metabolites in the skin in human allergic and irritant contact dermatitis. Br J Dermatol 1984;111: 23-28.